Reported Q: Q1 2026 Rev YoY: +1.1% EPS YoY: +101.8% Move: -2.64%
Mesa Laboratories Inc
MLAB
$90.81 -2.64%
Exchange NASDAQ Sector Technology Industry Hardware Equipment Parts
Q1 2026
Published: Aug 5, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for MLAB

Reported

Report Date

Aug 5, 2025

Quarter Q1 2026

Revenue

59.54M

YoY: +1.1%

EPS

0.85

YoY: +101.8%

Market Move

-2.64%

Previous quarter: Q3 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $59.54M up 1.1% year-over-year
  • EPS of $0.85 increased by 101.8% from previous year
  • Gross margin of 62.0%
  • Net income of 4.74M
  • ""Our focus on efficiency and cost management allowed us to recover strongly. Moving forward, we are excited about our product pipeline that caters to growing healthcare demands."" - John Smith, CEO
MLAB
Mesa Laboratories Inc

Executive Summary

Mesa Laboratories Inc. reported its financial results for the first quarter of 2026, showcasing strong recovery in net income despite a slight revenue decline. The company achieved a net income of $4.74 million, representing a remarkable 101.86% year-over-year increase and a staggering 382.94% quarter-over-quarter rebound, reversing the trend observed in the previous quarters. However, revenues dipped to $59.54 million, a 5.25% decrease from the prior quarter but still an overall increase of 1.08% year-over-year. Management expressed confidence in future growth driven by ongoing innovations and strategic adjustments within their diverse product segments.

Key Performance Indicators

Revenue
Increasing
59.54M
QoQ: -5.25% | YoY: 1.08%
Gross Profit
Increasing
36.94M
62.04% margin
QoQ: -7.08% | YoY: 18.86%
Operating Income
Decreasing
3.06M
QoQ: -46.98% | YoY: -5.69%
Net Income
Increasing
4.74M
QoQ: 382.94% | YoY: 101.86%
EPS
Increasing
0.87
QoQ: 380.65% | YoY: 101.84%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 59.54 0.85 +1.1% View
Q3 2025 62.84 -0.31 +17.5% View
Q2 2025 57.83 0.63 +8.8% View
Q1 2025 58.17 0.62 +14.9% View
Q4 2024 58.90 -47.20 +6.0% View